PicoCELA Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • November 20th, 2024 • PicoCELA Inc. • Electric lighting & wiring equipment • New York
Contract Type FiledNovember 20th, 2024 Company Industry Jurisdiction
CHROMOCELL THERAPEUTICS CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • October 16th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 16th, 2023 Company Industry JurisdictionChromocell Therapeutics Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of [ ] shares (the “Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”) to the several underwriters (such underwriters, for whom Titan Partners Group LLC, a division of American Capital Partners, LLC (“Titan Partners” or the “Representative”) is acting as representative, the “Underwriters” and each an “Underwriter”). Such Shares are hereinafter collectively called the “Firm Shares.” The Company has also agreed to grant to the Representative on behalf of the Underwriters an option (the “Option”) to purchase up to an additional [ ] shares of Common Stock (the “Option Shares”) on the terms set forth in Section 1(b) hereof. The Shares included in the Firm Shares and the Option Shares are hereinafter collectively called the “Public Securities.” The Public Securities and the Representative
LIPELLA PHARMACEUTICALS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 13th, 2022 • Lipella Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 13th, 2022 Company Industry Jurisdiction
LIPELLA PHARMACEUTICALS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 8th, 2022 • Lipella Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 8th, 2022 Company Industry Jurisdiction